AB Capital Surges on Strong Q3, Advent Deal Boosts Housing Arm

BANKINGFINANCE
Whalesbook Logo
AuthorKavya Nair|Published at:
AB Capital Surges on Strong Q3, Advent Deal Boosts Housing Arm
Overview

Aditya Birla Capital's shares climbed following a strong third quarter, marked by a 28.7% profit surge to ₹772 crore and 24% AUM growth to ₹1.48 lakh crore. A strategic ₹2,750 crore capital infusion into its housing finance subsidiary from Advent International further bolsters its expansion plans. The company's diversified business segments, including life and health insurance, also demonstrated healthy performance metrics, positioning it favorably within the buoyant Indian financial services sector.

Aditya Birla Capital Ltd. saw its stock price advance in early trading on Wednesday, February 4, 2026, building on positive momentum from its recently announced robust third-quarter financial results. The company reported a consolidated profit after tax of ₹772 crore, a significant 28.7% increase year-over-year from ₹600 crore in the prior year period. This growth was underpinned by a healthy expansion in net interest income, which rose 22.7% to ₹2,127 crore, and a 22.2% increase in pre-provision operating profit (PPOP) to ₹1,458 crore. The firm's net interest margins (NIMs) showed sequential improvement, edging up to 6.12% from 6.06%, while return on assets (ROA) expanded to 2.25% from 2.20% in the preceding quarter.

Diversified Business Momentum

The company's overall Assets Under Management (AUM) demonstrated substantial growth, increasing by 24% year-on-year to ₹1.48 lakh crore. The housing finance segment was a particular highlight, with its AUM growing by an impressive 48% to ₹42,000 crore and its ROA improving to 1.96%. The asset management (AMC) business also contributed, posting an 11% rise in domestic AUM to ₹4.43 lakh crore. Performance in the insurance arms was equally encouraging: the life insurance business saw value of new business (VNB) margins expand by 300 basis points sequentially to 14.6%, while the health insurance business improved its combined ratio to 111% and gained market share to 14.2%.

Strategic Capital Infusion Fuels Expansion

Further solidifying its growth trajectory, Aditya Birla Capital's board has approved a significant capital infusion of ₹2,750 crore into its housing finance subsidiary, Aditya Birla Housing Finance Limited (ABHFL). This investment is being made by Indriya Limited, an entity affiliated with global private equity firm Advent International, which previously held a stake in Aditya Birla Capital until its exit in late 2025. The deal values ABHFL at ₹19,250 crore on a post-money basis and Advent International will acquire a 14.3% stake. This strategic capital injection is poised to accelerate ABHFL's market expansion and strengthen its balance sheet, aligning with management's target for ROA to reach 2.5% levels within the next four to five quarters.

Market Context and Analyst Outlook

Aditya Birla Capital operates in a robust Indian financial services sector, which is projected to experience sustained growth, with NBFCs expected to expand at 16% annually. The company's market capitalization stands at approximately ₹87,000-₹90,000 crore, with a trailing twelve-month (TTM) Price-to-Earnings (P/E) ratio in the range of 25-28x. This valuation places it competitively against peers such as Bajaj Finance (P/E ~36x) and Shriram Finance (P/E ~20x). Analysts maintain a generally positive outlook, with a consensus 'Buy' rating and average price targets around ₹360-₹390, suggesting potential upside from current trading levels. The company's stock has seen substantial appreciation, gaining over 107% in the past year [cite: News1], reflecting strong investor confidence in its diversified business model and growth initiatives. The positive market reaction to the Advent International capital infusion, which saw shares jump significantly on February 3rd, highlights investor appetite for strategic capital allocation aimed at expansion.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.